✦ LIBER ✦

P1183 VIRAL BREAKTHROUGH DURING TRIPLE THERAPY: CAUSES OF NON RESPONSE IN A MULTICENTRIC COHORT

✍ Scribed by Calleja Panero, J.L.; Crespo, J.; Rodríguez, R.; Serra, M.A.; Pascasio, J.M.; Sola, R.; Morillas, R.; Romero, M.; Lens, S.; García Samaniego, J.; Ruiz Antorán, B.; Turnes, J.

Book ID: 122104998
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 58 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61343-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P910 IMPACT OF ANEMIA IN VIRAL RESPONSE

P910 IMPACT OF ANEMIA IN VIRAL RESPONSE DURING TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTS

✍ Vinaixa, C.; Coilly, A.; Garcia, M.; Rubin, A.; Aguilera, V.; Prieto, M.; Duclos 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

✍ Manns, M.; Muir, A.; Adda, N.; Jacobson, I.; Afdhal, N.; Heathcote, J.; Zeuzem, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

751d SVR Results of Prove3, a Phase 2B C

751d SVR Results of Prove3, a Phase 2B Clinical Trial Assessing Safety and Efficacy of Telaprevir in Hepatitis C Genotype-1-Infected Patients with Prior Non-Response, Viral Breakthrough or Relapse to Peginterferon-Alfa-2a/B and Ribavirin Therapy

✍ Adrian M. Di Bisceglie; Andrew M.J. Muir; Nathalie Adda; Ira M. Jacobson; Nezam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB